ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
+25.05%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$18.7B
AUM Growth
+$4.8B
(+35%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
10.18%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,702
New
548
Increased
855
Reduced
264
Closed
34
Top Buys
| 1 |
Amazon
AMZN
|
+$160M |
| 2 |
Microsoft
MSFT
|
+$140M |
| 3 |
Apple
AAPL
|
+$138M |
| 4 |
Carrier Global
CARR
|
+$113M |
| 5 |
Otis Worldwide
OTIS
|
+$97.3M |
Top Sells
| 1 |
Clorox
CLX
|
+$52.5M |
| 2 |
Abbott
ABT
|
+$25.4M |
| 3 |
Colgate-Palmolive
CL
|
+$25.1M |
| 4 |
Hormel Foods
HRL
|
+$23.5M |
| 5 |
Kimberly-Clark
KMB
|
+$21.5M |
Sector Composition
| 1 | Technology | 22.9% |
| 2 | Consumer Discretionary | 13.41% |
| 3 | Industrials | 11.78% |
| 4 | Financials | 10.2% |
| 5 | Healthcare | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
CRISPR Therapeutics
CRSP
$5.03B
| $717K | ﹤0.01% |
9,751
+1,556
| +19% | +$114K |
|
802
Cognex
CGNX
$7.45B
| $715K | ﹤0.01% |
11,966
+5,130
| +75% | +$307K |
|
803
Qualys
QLYS
$4.89B
| $712K | ﹤0.01% |
6,847
+4,342
| +173% | +$452K |
|
804
Charles River Laboratories
CRL
$7.69B
| $711K | ﹤0.01% |
4,079
+1,391
| +52% | +$242K |
|
805
Entegris
ENTG
$12.7B
| $708K | ﹤0.01% |
11,989
+1,378
| +13% | +$81.4K |
|
806
First Solar
FSLR
$21.9B
| $708K | ﹤0.01% |
14,305
+6,234
| +77% | +$309K |
|
807
Texas Roadhouse
TXRH
$11.1B
| $707K | ﹤0.01% |
13,455
+6,939
| +106% | +$365K |
|
808
ASGN Inc
ASGN
$2.29B
| $706K | ﹤0.01% |
+10,591
| New | +$706K |
|
809
East-West Bancorp
EWBC
$15.1B
| $706K | ﹤0.01% |
19,468
+4,861
| +33% | +$176K |
|
810
Zai Lab
ZLAB
$3.64B
| $703K | ﹤0.01% |
8,562
+3,438
| +67% | +$282K |
|
|
RETA
811
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $702K | ﹤0.01% |
4,500
-616
| -12% | -$96.1K |
|
812
Blackbaud
BLKB
$3.39B
| $701K | ﹤0.01% |
12,285
+5,773
| +89% | +$329K |
|
|
KRTX
813
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $700K | ﹤0.01% |
6,282
+2,083
| +50% | +$232K |
|
814
Lumentum
LITE
$11.6B
| $698K | ﹤0.01% |
8,570
-1,744
| -17% | -$142K |
|
815
American Airlines Group
AAL
$8.55B
| $696K | ﹤0.01% |
53,231
-257,899
| -83% | -$3.37M |
|
|
BLUE
816
DELISTED
bluebird bio
BLUE
| $695K | ﹤0.01% |
879
+213
| +32% | +$168K |
|
817
Neogen
NEOG
$1.21B
| $691K | ﹤0.01% |
17,822
+8,156
| +84% | +$316K |
|
|
SRC
818
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $691K | ﹤0.01% |
19,834
+4,766
| +32% | +$166K |
|
819
Molson Coors Class B
TAP
$9.57B
| $688K | ﹤0.01% |
20,017
+3,415
| +21% | +$117K |
|
820
Live Nation Entertainment
LYV
$40.5B
| $687K | ﹤0.01% |
15,507
+2,681
| +21% | +$119K |
|
|
AMTD
821
DELISTED
TD Ameritrade Holding Corp
AMTD
| $687K | ﹤0.01% |
18,894
+2,107
| +13% | +$76.6K |
|
822
Pacira BioSciences
PCRX
$1.22B
| $685K | ﹤0.01% |
13,056
+4,237
| +48% | +$222K |
|
823
Strategic Education
STRA
$2.01B
| $685K | ﹤0.01% |
4,458
+2,853
| +178% | +$438K |
|
|
RALS
824
DELISTED
ProShares RAFI Long/Short
RALS
| $682K | ﹤0.01% |
21,972
-775
| -3% | -$24.1K |
|
825
Caesars Entertainment
CZR
$5.28B
| $681K | ﹤0.01% |
+16,996
| New | +$681K |
|